Identification Predictive Markers of Immunochemotherapy Response to the Primary Cutaneous Diffuse Large B Cell Lymphoma
Condition(s):Lymphoma, Large B-Cell, DiffuseLast Updated:April 29, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Lymphoma, Large B-Cell, DiffuseLast Updated:April 29, 2020Unknown status
Condition(s):Advanced Diffuse Large B-Cell Lymphoma; Extra-nodal Involvement, Large Mass; RadiotherapyLast Updated:May 25, 2023Not yet recruiting
Condition(s):Breast CancerLast Updated:November 24, 2023Recruiting
Condition(s):Non-Hodgkin’s LymphomaLast Updated:August 6, 2019Completed
Condition(s):Lung CancerLast Updated:March 4, 2024Recruiting
Condition(s):BiomarkersLast Updated:April 26, 2021Unknown status
Condition(s):Breast Cancer FemaleLast Updated:May 10, 2021Completed
Condition(s):Non-Small Cell Lung CancerLast Updated:August 3, 2023Recruiting
Condition(s):Non-Small Cell Lung CancerLast Updated:August 13, 2021Unknown status
Condition(s):Hepatocellular Carcinoma; Metastatic CancerLast Updated:May 19, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.